The US FDA approved Eli Lilly's Zepbound as the first ever medication for obstructive sleep apnea for patients who also have ...

Anti-obesity medication use was associated with reduced alcohol consumption among patients in a telehealth medical weight ...

Elon Musk has admitted to taking a weight-loss drug in a Christmas Day post on X, formerly Twitter, as he shared a picture of ...

People today have many more options to help with obesity. If you are interested in trying an anti-obesity medication, talk with a doctor. GLP-1 drugs are becoming increasingly popular for their ...

The Biden administration proposed expanding coverage of weight loss medication to Medicaid and Medicare recipients. RFK Jr.

This proposed rule signals an important shift in the federal approach to obesity management, aligning with the medical ...

The Food and Drug Administration on Friday approved Eli Lilly’s weight-loss drug Zepbound to treat sleep apnea, a common but ...

The Food and Drug Administration on Friday approved Eli Lilly’s anti-obesity drug Zepbound as the first prescription medicine for obstructive sleep apnea, marking a major shift in the treatment ...

As anti-obesity medications gain popularity ... with over 12% of the population having tried the medication at least once, and probably at least 6% of the people currently with a prescription ...

Obesity has emerged as one of the most pressing public health challenges globally, affecting over 650 million adults, ...

Like Ozempic, Mounjaro, the brand name for tirzepatide, is an injectable type-2 diabetes medication taken once a week, which is also used as an anti-obesity medication. Alongside diet and exercise ...

However, pharmaceutical options remain outside the scope of coverage. Advocates for anti-obesity medication coverage argue that obesity is not merely a lifestyle issue but a complex condition ...